The anti-malarial drug, hydroxychloroquine, was shown to markedly reduce the levels of pro-inflammatory cytokines (IL-1β, IL-6, and tumor necrosis factor alpha [TNF-α]) because it exerts its anti-inflammatory effects in the treatment of acute kidney injury.8 The gene discussed is TNF; the disease is acute kidney injury.